Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard S Goldstein

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Critical Care Clinics|December 8, 2004
Management of the critically ill patient in the emergency department: focus on safety issuesRichard S Goldstein
Arthritis Research & Therapy|June 19, 2008
High mobility group box-1 protein as a tumor necrosis factor-independent therapeutic target in rheumatoid arthritisRichard S Goldstein
Bulletin of the American College of Surgeons|April 5, 2011
Importance of conflict disclosureRichard S Goldstein
The Journal of Emergency Medicine|February 15, 2005
Axillary artery aneurysmSanjey Gupta, David C Lee, Richard S Goldstein, et al.
Molecular Medicine (Cambridge, Mass.)|July 14, 2009
The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGEMauricio Rosas-Ballina, Richard S Goldstein, Margot Gallowitsch-Puerta, et al.
Bioelectronic Medicine|April 2, 2020
Investigational treatment of rheumatoid arthritis with a vibrotactile device applied to the external earMeghan E Addorisio, Gavin H Imperato, Alex F de Vos, et al.
Critical Care Medicine|September 29, 2007
Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsisJared M Huston, Margot Gallowitsch-Puerta, Mahendar Ochani, et al.
Molecular Medicine (Cambridge, Mass.)|June 29, 2007
Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritisRichard S Goldstein, Annette Bruchfeld, Lihong Yang, et al.
Shock (Augusta, Ga.)|May 25, 2006
Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemiaRichard S Goldstein, Margot Gallowitsch-Puerta, Lihong Yang, et al.
Molecular Medicine (Cambridge, Mass.)|June 28, 2008
Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signalingWilliam R Parrish, Mauricio Rosas-Ballina, Margot Gallowitsch-Puerta, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Critical Care Clinics|December 8, 2004
Management of the critically ill patient in the emergency department: focus on safety issuesRichard S Goldstein
Arthritis Research & Therapy|June 19, 2008
High mobility group box-1 protein as a tumor necrosis factor-independent therapeutic target in rheumatoid arthritisRichard S Goldstein
Bulletin of the American College of Surgeons|April 5, 2011
Importance of conflict disclosureRichard S Goldstein
The Journal of Emergency Medicine|February 15, 2005
Axillary artery aneurysmSanjey Gupta, David C Lee, Richard S Goldstein, et al.
Molecular Medicine (Cambridge, Mass.)|July 14, 2009
The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGEMauricio Rosas-Ballina, Richard S Goldstein, Margot Gallowitsch-Puerta, et al.
Bioelectronic Medicine|April 2, 2020
Investigational treatment of rheumatoid arthritis with a vibrotactile device applied to the external earMeghan E Addorisio, Gavin H Imperato, Alex F de Vos, et al.
Critical Care Medicine|September 29, 2007
Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsisJared M Huston, Margot Gallowitsch-Puerta, Mahendar Ochani, et al.
Molecular Medicine (Cambridge, Mass.)|June 29, 2007
Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritisRichard S Goldstein, Annette Bruchfeld, Lihong Yang, et al.
Shock (Augusta, Ga.)|May 25, 2006
Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemiaRichard S Goldstein, Margot Gallowitsch-Puerta, Lihong Yang, et al.
Molecular Medicine (Cambridge, Mass.)|June 28, 2008
Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signalingWilliam R Parrish, Mauricio Rosas-Ballina, Margot Gallowitsch-Puerta, et al.
Pageof 1